Refine Search
(11)
(22)
(42)
(63)

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2019

  • $2,000
  • September 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2019’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

The report provide...

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2019

  • $2,000
  • September 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2019’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape.

The report provides comprehensive information on the thera...

Encephalitis - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalitis - Pipeline Review, H2 2019’, provides an overview of the Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalitis, comple...

Sedation - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sedation - Pipeline Review, H2 2019’, provides an overview of the Sedation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sedation, complete with anal...

Complex Regional Pain Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H2 2019’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Tourette Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H2 2019’, provides an overview of the Tourette Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tourette S...

Restless Legs Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Restless Legs Syndrome - Pipeline Review, H2 2019’, provides an overview of the Restless Legs Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Obsessive-Compulsive Disorder - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2019’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Fatigue - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fatigue - Pipeline Review, H2 2019’, provides an overview of the Fatigue pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysi...

Hyperalgesia - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H2 2019’, provides an overview of the Hyperalgesia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperalgesia, comple...

Cluster Headache Syndrome - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cluster Headache Syndrome - Pipeline Review, H2 2019’, provides an overview of the Cluster Headache Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Depression - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2019’, provides an overview of the Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Depression, complete wit...

Mild Cognitive Impairment - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2019’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Epilepsy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2019’, provides an overview of the Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with anal...

Alzheimer's Disease - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2019’, provides an overview of the Alzheimer's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...